Diatech Pharmacogenetics srl of Jesi at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Diatech Pharmacogenetics srl

Via Ignazio Silone 1b, 60035 Jesi
Telephone +39 0731 213243
Fax +39 0731 213239

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Hall map

MEDICA 2021 hall map (Hall 1): stand D45

Fairground map

MEDICA 2021 fairground map: Hall 1


Michela Romiti

Export Manager at Diatech Pharmacogenetics



Grit Lange

International Business Development Manager



Maria Luisa Biondi

Corporate Event Trade Manager



Davide De Luca

Business Development Manager Oncology



Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.03  Diagnostic tests for cancer
  • 03  Diagnostic tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.01  DNA testing

Our products

Product category: DNA testing, Diagnostic tests for cancer

EasyPGX® product line – The qPCR solution in oncology

Key features
  • Ready to use: reagents are delivered in 8-well strips preloaded with a complete master mix in a dry, room temperature and stable format.
  • Easy to use: no need for freezing, thawing, or pipetting on ice and the few remaining pipetting steps minimize the risk of errors or contaminations.
  • High sensitivity: limit of detection as low as 0.5%.
  • Flexible sample requirement: low DNA input from a variety of sources, including FFPE and plasma.
  • Turnaround time: from tissue to result in less than 3 hours with only 10 minutes of hands-on time.
  • Quality assurance: manufactured under ISO 13485.
  • Regulatory: kits have been designed, developed and validated in accordance with directive 98/79/EC on in vitro diagnostic medical devices.
  • EasyPGX system workflow: from tissue to result in less than 3 hours.
Complete tests CE IVD portfolio for:
  • Colorectal cancer
  • Lung cancer
  • Melanoma
  • Thyroid cancer
  • Cervical cancer
  • Breast cancer
  • Glioblastoma
  • Genotyping assays
  • Liquid biopsy assays

More Less

Product category: DNA testing

Helix® Circulating

The kit allows the manual extraction of circulating free DNA (cfDNA) from plasma. The kit Helix® Circulating Nucleic Acid, in association with the kit Easy® EGFR, enables the mutational analysis of EGFR gene in the circulating tumor DNA (liquid biopsy) when the tumor tissue is not evaluable, according to the EMA/129677/2014 recommendations of September 25th 2014.

More Less

About us

Company portrait

Diatech Pharmacogenetics is the Italian leader in the development, production and commercialisation of pharmacogenetics tests for cancer precision medicine.
Founded in 1996, Diatech Pharmacogenetics has sustained constant organic growth over the years and now owns more than 70% of the Italian molecular diagnostic market and it is rapidly growing worldwide; to date, more than 20.000 diagnostic tests have been performed using its solutions and every year Diatech Pharmacogenetics reinvests 20% of it revenues in R&D.
Diatech Pharmacogenetics is able to take pharmacogenetics tests from idea to market on a variety of platforms, from real-time PCR to barcoded microarrays, mass-spectrometry and next generation sequencing, supplying all reagents, instruments, materials and support necessary. Its complete solutions guide diagnostic operators from sample extraction, quality control, molecular assay to bioinformatic analysis and report.
The latest products launched include a liquid biopsy cfDNA extraction kit, a real-time PCR system with all reagent provided in a dry and stable format, micro-satellite instability assays and an end-to-end NGS solution that works on both Illumina and IonTorrent platforms.
All Diatech products are developed under EN ISO 9001 and EN ISO 13485 and have been designed, developed and validated in accordance with the Directive 98/79/EC on in vitro diagnostic medical devices (CE-IVD).

Company data

Sales volume 10-49 Mio US $
Export content max. 25%
Number of employees 50-99
Foundation 1996
Area of business
  • Laboratory equipment
  • Diagnostic tests